Reinvent Executives to Speak on Metaswitch Expertise and Cloud CX at Alianza Navigate 25
CEO Justin Catlett and VP of Sales Ray Napoletano will highlight lessons from years of Metaswitch deployments and explore strategies for growth with cloud-native... Read more.
SBS CyberSecurity Reports Record Surge in TRAC Adoption, Signaling Industry Shift Toward Modern GRC Solutions
MADISON, S.D., Sept. 19, 2025 /PRNewswire/ — As financial institutions face increasing cyber threats alongside stricter regulatory demands, SBS CyberSecurity... Read more.
EVE Energy Achieves World’s First 400MWh Energy Storage Project with 628Ah Ultra-Large Cells
WUHAN, China, Sept. 19, 2025 /PRNewswire/ — As a pioneer in big-batteries technology, EVE Energy has set a new industry milestone, building on its prior success... Read more.
Stealth BioTherapeutics Announces FDA Accelerated Approval of FORZINITY™ (elamipretide HCl), the First Therapy for Progressive and Life-limiting Ultra-rare Genetic Disease Barth Syndrome
NEEDHAM, Mass., Sept. 19, 2025 /PRNewswire/ — Stealth BioTherapeutics Inc. (the “Company” or “Stealth”), a commercial-stage biotechnology... Read more.
Neue Alchemy Launches AU79 Records in Under 24 Hours
Debut release from Vanta Noir drops on YouTube and DSPs. Next up: Lyon Drive — founder Isaiah Steinfeld returns to the mic. ALCHMY Coffee relaunches in parallel... Read more.
Helser Brothers to Showcase the One-of-a-Kind Motorized French Pole at CWC 2025
The new Vervo Motorized Traverse French Pole seamlessly blends elegance with modern automation, offering designers the best of both worlds. CHANDLER, Ariz., Sept.... Read more.
Casekoo Tops 1.27 Million Magic Stand Case Sales
NEW YORK, Sept. 19, 2025 /PRNewswire/ — CASEKOO, a leading innovator in premium smartphone protection, today announced the remarkable sale of over 1.27 million... Read more.
TREMFYA® (guselkumab) achieves U.S. approval for subcutaneous induction in adults with ulcerative colitis, now the first and only IL-23 inhibitor with a fully subcutaneous regimen
TREMFYA® offers the flexibility of self-administration from the start of treatment, building on the prior approval of subcutaneous induction in Crohn’s disease... Read more.
PINTEC ANNOUNCES UNAUDITED FINANCIAL RESULTS FOR THE FIRST HALF OF 2025
BEIJING, Sept. 19, 2025 /PRNewswire/ — Pintec Technology Holdings Limited (Nasdaq: PT) (“Pintec” or the “Company”), a Nasdaq-listed... Read more.
RBI Recommends Shareholders Reject Ocehan’s “Mini-tender Offer”
MIAMI, Sept. 19, 2025 /PRNewswire/ – Restaurant Brands International Inc. (NYSE: QSR) (TSX: QSR) (“RBI”) has been notified of an unsolicited mini-tender... Read more.